RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 20 - per page Next page
Order by
Profiled on pharmalicensing.com Orpha Swiss GmbH
OrPha Swiss is looking of in - and out-licensing opportunities in the field of anaesthesia, intensive care, neurology, pulmonary hypertension and addiction medicine More
Palau Pharma
Palau Pharma is a product-driven biopharmaceutical company focused on the discovery and development of new medicines for the treatment of inflammatory and autoimmune diseases. More
Merck KGaA
Focus is on innovations in pharmaceuticals and chemicals More
Jelfa Pharmaceutical Company
Production, distribution and marketing of solid, semi-solid and injectable preparations. More
RAFARM
Development & Marketing of Pharmaceuticals for Human Use More
Biomedica Foscama
Biomedica Foscama is committed in development, production and marketing of prescription pharmaceuticals. The main focus is on cardiovascular, CNS, GI/metabolism and hospital products. More
Ardana Bioscience
Ardana Bioscience is a speciality pharmaceutical company which aims to discover, develop and market innovative products which promote better reproductive health and address the considerable unmet need More
AstraZeneca
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
Laboratorios Rubió
LABORATORIOS RUBIÓ specialises in the development, manufacture and marketing of APIs and finished dosage forms of niche products More
SPEEDEL Pharma
Speedel Holding AG is a Swiss-based drug development company focused on the development of pharmaceuticals that address cardiovascular and metabolic diseases. More
Displaying 1..10 of 20 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Abbott Laboratories: PharmaVitae Report
May 2011 - 95 pages - $5,700
Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular Abnormalities
Jul 2010 - 6 pages - $500
Eli Lilly & Co.: PharmaVitae Report
Jun 2011 - 92 pages - $5,700
Eli Lilly & Co.: PharmaVitae Profile
Jul 2010 - 101 pages - $5,700
Transcatheter Cardiovascular Therapeutics (TCT) 2009: Conference Review and Analysis
Oct 2009 - 40 pages - $1,000
Apotex Inc.: PharmaVitae Profile
Dec 2010 - 37 pages - $5,700
Australia Cardiovascular Devices Market Analysis and Forecasts to 2015
Jul 2009 - 279 pages - $3,500
World Market for Prescription Generic Drugs, 6th Edition
Apr 2008 - 250 pages - $3,995
H. Lundbeck A/S: PharmaVitae Profile
Dec 2010 - 58 pages - $5,700
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us